Key result
Surgical resection of malignant cardiac tumors resulted in no 30-day mortality and a median overall survival of 11 months, though complete (R0) resection was achieved in only 20% of patients.
Why the study?
Malignant cardiac tumors are rare with poor prognosis, and the efficacy of surgical resection performed for symptom relief and survival benefit is limited.
Observational (n=15)
No
Surgical resection of malignant cardiac tumors is feasible with acceptable perioperative safety, though complete resection is rare and long-term survival remains poor, particularly for angiosarcomas.
PURPOSE: Malignant cardiac tumors are rare and have a poor prognosis. Surgical resection is performed for symptom relief and survival benefit, but its efficacy is limited. We reviewed our 20-year single-institution experience with primary and metastatic malignant cardiac tumors. METHODS: We retrospectively reviewed 15 patients who underwent resection for histologically confirmed malignant cardiac tumors between 2006 and 2025. Data included tumor characteristics, resection status, and survival outcomes. RESULTS: Of 15 patients, 7 (46.7%) had primary tumors (most common: angiosarcoma) and 8 (53.3%) had metastatic lesions. The right atrium was the most frequent site (60.0%). Complete (R0) resection was achieved in only 3 cases (20.0%). Median overall survival (OS) for the cohort was 11 months. Patients with angiosarcoma had particularly poor outcomes (median OS: 5 months). One patient with metastatic thymic carcinoma achieved long-term survival (>15 years) following multimodal therapy. Adjuvant therapy was administered in 7 patients (46.7%). No 30-day postoperative mortality occurred. CONCLUSION: Surgical resection of malignant cardiac tumors is feasible with acceptable perioperative safety. Although R0 resection is rarely attainable and long-term outcomes remain poor, particularly for high-grade sarcomas, a multimodal approach is essential to optimize outcomes in selected patients.
No takes yet. Share an insight, caveat, or question.
Nakanishi et al. (2026) conducted an observational in Malignant cardiac tumors (n=15). Surgical resection was evaluated on Median overall survival (months) (95% CI 2-39). Surgical resection of malignant cardiac tumors resulted in no 30-day mortality and a median overall survival of 11 months, though complete (R0) resection was achieved in only 20% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: